SCHEMBL6591684

SCHEMBL6591684

Cc1c(-c2cc3cc(C(=O)Nc4nc5ccccc5s4)ccc3o2)oc(=O)c(C)c1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 2/20 0.53
SCD O00767 4/20 0.52
KDM4E B2RXH2 6/20 0.49
HTT P42858 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
RAB9A P51151 10/20 0.48
NPC1 O15118 9/20 0.48
MEN1 O00255 7/20 0.48
KMT2A Q03164 7/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48
RELA Q04206 2/20 0.48
LMNA P02545 2/20 0.48
DHODH Q02127 2/20 0.47
MAPT P10636 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6591256 0.81 LMNA (0.50) KDM4ERAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL6592536 0.81 ACHE (0.40) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL6595673 0.80 RAB9A (0.52) SCDKDM4EHTTRAB9ANPC1
SCHEMBL6595680 0.76 NPC1 (0.42) L3MBTL1RAB9ANPC1MEN1KMT2A
SCHEMBL6590650 0.76 HPGD (0.51) KDM4EHTTL3MBTL1RAB9ANPC1
SCHEMBL6593096 0.75 HDAC6 (0.39) KDM4ERAB9ANPC1SMN1; SMN2NFKB1
SCHEMBL6595885 0.75 TP53 (0.46) KDM4EL3MBTL1MAPTALDH1A1HPGD
SCHEMBL6590728 0.74 THRB (0.49) KDM4EHTTRAB9ANPC1MEN1
SCHEMBL6596160 0.73 NT5E (0.49) L3MBTL1MEN1KMT2AMAPT
SCHEMBL6596195 0.72 GAA (0.46) KDM4EHTTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP disclosed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US disclosed
US-6589984-B1 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as TEIJIN LIMITED (JP) 2003-07-08 US disclosed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186976-A1 Benzofurylpyrone derivatives PLIN5, ACSL5, PLIN1 TOP1 1120/4885SCD 202/4885KDM4E 1274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.